B cells that produce immunoglobulin e mediate colitis in BALB/c mice

Gastroenterology

Volumn 142, Issue 1, 2012, Pages 96-108

  Hoving, Jennifer C ^a   Kirstein, Frank ^a   Nieuwenhuizen, Natalie E ^a   Fick, Lizette C E ^a   Hobeika, Elias ^b,c   Reth, Michael ^b,c   Brombacher, Frank ^a,d  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF FREIBURG   (Germany)

^c MAX PLANCK INSTITUTE OF IMMUNOBIOLOGY AND EPIGENETICS   (Germany)

^d INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

IBD; Immune Regulation; Inflammatory Bowel Disease; T Cell Signaling

Indexed keywords

IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR ALPHA; OXAZOLONE;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL PROTECTION; COLITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNOGLOBULIN PRODUCTION; LYMPHOCYTE FUNCTION; MALE; MAST CELL; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; TH2 CELL;

EID: 83955161231     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2011.09.044     Document Type: Article

References (52)

1. G. Bouma, W. Strober The immunological and genetic basis of inflammatory bowel disease Nat Rev Immunol 3 2003 521 533
2. S. Lichtiger, D.H. Present, A. Kornbluth Cyclosporine in severe ulcerative colitis refractory to steroid therapy N Engl J Med 330 1994 1841 1845
3. K. Kett, T.O. Rognum, P. Brandtzaeg Mucosal subclass distribution of immunoglobulin G-producing cells is different in ulcerative colitis and Crohn's disease of the colon Gastroenterology 93 1987 919 924
4. M. Boirivant, I.J. Fuss, A. Chu Oxazolone colitis: a murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4 J Exp Med 188 1998 1929 1939
5. R. Kojima, S. Kuroda, T. Ohkishi Oxazolone-induced colitis in BALB/C mice: a new method to evaluate the efficacy of therapeutic agents for ulcerative colitis J Pharmacol Sci 96 2004 307 313
6. X. Wang, Q. Ouyang, W.J. Luo Oxazolone-induced murine model of ulcerative colitis Chin J Dig Dis 5 2004 165 168
7. P. Mombaerts, E. Mizoguchi, M.J. Grusby Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice Cell 75 1993 274 282
8. P.J. Morrissey, K. Charrier, S. Braddy CD4+ T cells that express high levels of CD45RB induce wasting disease when transferred into congenic severe combined immunodeficient mice Disease development is prevented by cotransfer of purified CD4+ T cells J Exp Med 178 1993 237 244
9. F. Powrie T cells in inflammatory bowel disease: protective and pathogenic roles Immunity 3 1995 171 174
10. B. Sadlack, H. Merz, H. Schorle Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene Cell 75 1993 253 261
11. W. Strober, R.O. Ehrhardt Chronic intestinal inflammation: an unexpected outcome in cytokine or T cell receptor mutant mice Cell 75 1993 203 205
12. I. Takahashi, H. Kiyono, S. Hamada CD4+ T-cell population mediates development of inflammatory bowel disease in T-cell receptor alpha chain-deficient mice Gastroenterology 112 1997 1876 1886
13. C.O. Elson, R.B. Sartor, G.S. Tennyson Experimental models of inflammatory bowel disease Gastroenterology 109 1995 1344 1367
14. S. Okamoto, M. Watanabe, M. Yamazaki A synthetic mimetic of CD4 is able to suppress disease in a rodent model of immune colitis Eur J Immunol 29 1999 355 366
15. S.J. Simpson, E. Mizoguchi, D. Allen Evidence that CD4+, but not CD8+ T cells are responsible for murine interleukin-2-deficient colitis Eur J Immunol 25 1995 2618 2625
16. F. Brombacher The role of interleukin-13 in infectious diseases and allergy Bioessays 22 2000 646 656
17. F. Heller, I.J. Fuss, E.E. Nieuwenhuis Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells Immunity 17 2002 629 638
18. Y. van de Wal, N. Corazza, M. Allez Delineation of a CD1d-restricted antigen presentation pathway associated with human and mouse intestinal epithelial cells Gastroenterology 124 2003 1420 1431
19. F. Heller, P. Florian, C. Bojarski Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution Gastroenterology 129 2005 550 564
20. T. Kawano, J. Cui, Y. Koezuka CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides Science 278 1997 1626 1629
21. B.R. Yacyshyn Activated CD19+ B cell lamina propria lymphocytes in ulcerative colitis Immunol Cell Biol 71 1993 265 274
22. B.B. Ceyhan, S. Karakurt, H. Cevik Bronchial hyperreactivity and allergic status in inflammatory bowel disease Respiration 70 2003 60 66
23. T.T. MacDonald, G. Monteleone Immune mechanisms in inflammatory bowel disease Chapter 6 2006 Springer Science+Business Media New York, NY
24. M. Radwanska, A.J. Cutler, J.C. Hoving Deletion of IL-4Ralpha on CD4 T cells renders BALB/c mice resistant to Leishmania major infection PloS Pathog 3 2007 e68
25. E. Hobeika, S. Thiemann, B. Storch Testing gene function early in the B cell lineage in mb1-cre mice Proc Natl Acad Sci U S A 103 2006 13789 13794
26. M. Reth, J. Wienands Initiation and processing of signals from the B cell antigen receptor Ann Rev Immunol 15 1997 453 479
27. M. Mohrs, B. Ledermann, G. Kohler Differences between IL-4- and IL-4 receptor alpha-deficient mice in chronic leishmaniasis reveal a protective role for IL-13 receptor signaling J Immunol 162 1999 7302 7308
28. D.R. Herbert, C. Holscher, M. Mohrs Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology Immunity 20 2004 623 635
29. N. Noben-Trauth, P. Kropf, I. Muller Susceptibility to Leishmania major infection in interleukin-4-deficient mice Science 271 1996 987 990
30. G.J. McKenzie, A. Bancroft, R.K. Grencis A distinct role for interleukin-13 in Th2-cell-mediated immune responses Curr Biol 8 1998 339 342
31. M.F. Neurath, B. Weigmann, S. Finotto The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease J Exp Med 195 2002 1129 1143
32. F. Kirstein, W.G. Horsnell, D.A. Kuperman Expression of IL-4Rα on smooth muscle cells is not necessary for development of experimental allergic asthma J Allergy Clin Immunol 126 2010 347 354
33. W.G. Horsnell, A.J. Cutler, J.C. Hoving Delayed goblet cell hyperplasia, acetylcholine receptor expression, and worm expulsion in SMC-specific IL-4Ralpha-deficient mice PLos Pathog 3 2007 e1
34. S. Wolfensohn, M. Lloyd Recognition of pain and stress in laboratory animals Handbook of laboratory animal management and welfare 1998 Blackwell Publishing Ltd Oxford, UK 59 62
35. H. Iijima, M.F. Neurath, T. Nagaishi Specific regulation of T helper cell 1-mediated murine colitis by CEACAM1 J Exp Med 199 2004 471 482
36. M. Mohrs, C. Holscher, F. Brombacher Interleukin-4 receptor alpha-deficient BALB/c mice show an unimpaired T helper 2 polarization in response to Leishmania major infection Infect Immun 68 2000 1773 1780
37. I. Fuss, W. Strober The role of IL-13 and NK T cells in experimental and human ulcerative colitis Mucosal Immunol Suppl 1 2008 S5 S9
38. D.G. Pellicci, K.J. Hammond, J. Coquet DX5/CD49b-positive T cells are not synonymous with CD1d-dependent NKT cells J Immunol 175 2005 4416 4425
39. Y. Liu, R.D. Goff, D. Zhou A modified alpha-galactosyl ceramide for staining and stimulating natural killer T cells J Immunol Methods 312 2006 34 39
40. K. Nelms, A.D. Keegan, J. Zamorano The IL-4 receptor: signaling mechanisms and biologic functions Ann Rev Immunol 17 1999 701 738
41. R.L. Coffman, J. Ohara, M.W. Bond B cell stimulatory factor-1 enhances the IgE response of lipopolysaccharide-activated B cells J Immunol 136 1986 4538 4541
42. C.M. Snapper, F.D. Finkelman, D. Stefany IL-4 induces co-expression of intrinsic membrane IgG1 and IgE by murine B cells stimulated with lipopolysaccharide J Immunol 141 1988 489 498
43. O.H. Kang, D.K. Kim, Y.A. Choi Suppressive effect of non-anaphylactogenic anti-IgE antibody on the development of dextran sulfate sodium-induced colitis Int J Mol Med 18 2006 893 899
44. C.A. Akdis Allergy and hypersensitivity: mechanisms of allergic disease Curr Opin Immunol 18 2006 718 726
45. F.D. Finkelman Anaphylaxis: lessons from mouse models J Allergy Clin Immunol 120 2007 506 515
46. M. Baniyash, M. Kehry, Z. Eshhar Anti-IgE monoclonal antibodies directed at the Fcε Receptor binding site Mol Immunol 25 1988 705 711
47. S. Schwarzbaum, A. Nissim, I. Alkalay Mapping of murine IgE epitopes involved in IgE-Fcε receptor interactions Eur J Immunol 19 1989 1015 1023
48. S.C. Bischoff, J. Wedemeyer, A. Herrmann Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel disease Histopathology 28 1996 1 13
49. M. Raithel, S. Winterkamp, A. Pacurar Release of mast cell tryptase from human colorectal mucosa in inflammatory bowel disease Scand J Gastroenterol 2 2001 174 179
50. H. Osterfeld, R. Ahrens, R. Strait Differential roles for the IL-9/IL-9 receptor alpha-chain pathway in systemic and oral antigen-induced anaphylaxis J Allergy Clin Immunol 125 2010 469 476 e462
51. A.P. Dick, M.J. Grayson, R.G. Carpenter Controlled trial of sulphasalazine in the treatment of ulcerative colitis Gut 5 1964 437 442
52. W.J. Sandborn, J. Regula, B.G. Feagan Delayed-release oral mesalamine 4.8 g/day (800-mg tablet) is effective for patients with moderately active ulcerative colitis Gastroenterology 137 2009 1934 1943 e19311933